Literature DB >> 9296780

Defective phagocytosis of apoptotic cells: possible explanation for the induction of autoantibodies in SLE.

J R Kalden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9296780     DOI： 10.1177/096120339700600326

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


× No keyword cloud information.
  7 in total

1.  Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus.

Authors:  A E M van Nieuwenhuijze; T van Lopik; R J T Smeenk; L A Aarden
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

Review 2.  Autoimmunity versus tolerance: can dying cells tip the balance?

Authors:  Irene C B Viorritto; Nikolay P Nikolov; Richard M Siegel
Journal:  Clin Immunol       Date:  2006-10-05       Impact factor: 3.969

3.  Reduced expression of CD44 on monocytes and neutrophils in systemic lupus erythematosus: relations with apoptotic neutrophils and disease activity.

Authors:  A P Cairns; A D Crockard; J R McConnell; P A Courtney; A L Bell
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

4.  Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents.

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Int J Clin Rheumtol       Date:  2011-08

Review 5.  Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve?

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Expert Rev Clin Immunol       Date:  2015-01       Impact factor: 4.473

6.  Genome-wide DNA methylation patterns in CD4+ T cells from patients with systemic lupus erythematosus.

Authors:  Matlock A Jeffries; Mikhail Dozmorov; Yuhong Tang; Joan T Merrill; Jonathan D Wren; Amr H Sawalha
Journal:  Epigenetics       Date:  2011-05-01       Impact factor: 4.528

7.  Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.

Authors:  Noelia A-Gonzalez; Steven J Bensinger; Cynthia Hong; Susana Beceiro; Michelle N Bradley; Noam Zelcer; Jose Deniz; Cristina Ramirez; Mercedes Díaz; German Gallardo; Carlos Ruiz de Galarreta; Jon Salazar; Felix Lopez; Peter Edwards; John Parks; Miguel Andujar; Peter Tontonoz; Antonio Castrillo
Journal:  Immunity       Date:  2009-07-30       Impact factor: 31.745
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.